Comparative effects of topiroxostat and febuxostat on arterial properties in hypertensive patients with hyperuricemia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative effects of topiroxostat and febuxostat on arterial properties in hypertensive patients with hyperuricemia
Authors
Keywords
-
Journal
Journal of Clinical Hypertension
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-01-06
DOI
10.1111/jch.14153
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2020 American College of Rheumatology Guideline for the Management of Gout
- (2020) John D. FitzGerald et al. ARTHRITIS CARE & RESEARCH
- Association of plasma xanthine oxidoreductase activity with blood pressure affected by oxidative stress level: MedCity21 health examination registry
- (2020) Shio Yoshida et al. Scientific Reports
- Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial
- (2020) Atsushi Tanaka et al. PLOS MEDICINE
- Uric acid and hypertension
- (2020) Miguel A. Lanaspa et al. HYPERTENSION RESEARCH
- Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy
- (2019) Sunao Kojima et al. EUROPEAN HEART JOURNAL
- Comparing Cardiovascular Safety of Febuxostat and Allopurinol in the Real World: A Population-Based Cohort Study
- (2019) Ching-Yen Su et al. MAYO CLINIC PROCEEDINGS
- The effects of topiroxostat on vascular function in patients with hyperuricemia
- (2019) Shingo Higa et al. Journal of Clinical Hypertension
- Class effect of xanthine oxidase inhibitors on flow‐mediated dilatation in hypertensive patients: A randomized controlled trial
- (2019) Satoshi Hoshide et al. Journal of Clinical Hypertension
- Insulin Resistance Associated with Plasma Xanthine Oxidoreductase Activity Independent of Visceral Adiposity and Adiponectin Level: MedCity21 Health Examination Registry
- (2019) Masafumi Kurajoh et al. International Journal of Endocrinology
- Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials
- (2018) Markus Bredemeier et al. BMC Cardiovascular Disorders
- Longitudinal association among endothelial function, arterial stiffness and subclinical organ damage in hypertension
- (2018) Hirofumi Tomiyama et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
- (2018) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renoprotective effects of topiroxostat for hyperuremic patients with overt diabetic nephropathy study (ETUDE Study): A prospective, randomized, multicenter clinical trial
- (2017) Toshihiro Mizukoshi et al. NEPHROLOGY
- Effect of uric acid-lowering therapy on blood pressure: systematic review and meta-analysis
- (2016) Li-hui Qu et al. ANNALS OF MEDICINE
- Serum uric acid is associated with non-dipping circadian pattern in young patients (30–40 years old) with newly diagnosed essential hypertension
- (2016) Francesco Giallauria et al. CLINICAL AND EXPERIMENTAL HYPERTENSION
- Effects of topiroxostat and febuxostat on urinary albumin excretion and plasma xanthine oxidoreductase activity in db/db mice
- (2016) Takashi Nakamura et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Morning and Evening Home Blood Pressure and Risks of Incident Stroke and Coronary Artery Disease in the Japanese General Practice PopulationNovelty and Significance
- (2016) Satoshi Hoshide et al. HYPERTENSION
- A highly sensitive assay of human plasma xanthine oxidoreductase activity using stable isotope-labeled xanthine and LC/TQMS
- (2016) Takayo Murase et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Hyperuricemia and the Prognosis of Hypertensive Patients: A Systematic Review and Meta-Analysis
- (2016) Tianqiang Qin et al. Journal of Clinical Hypertension
- Effects of Allopurinol on Arterial Stiffness: A Meta-Analysis of Randomized Controlled Trials
- (2016) Gang Deng et al. MEDICAL SCIENCE MONITOR
- Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease patients with or without gout
- (2014) Tatsuo Hosoya et al. Clinical and Experimental Nephrology
- Home Blood Pressure and Cardiovascular Outcomes in Patients During Antihypertensive Therapy
- (2014) Kazuomi Kario et al. HYPERTENSION
- The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014)
- (2014) HYPERTENSION RESEARCH
- Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: a systematic review and meta-analysis based on observational cohort studies
- (2014) Ling Li et al. BMC Nephrology
- Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: A meta-analysis of prospective studies
- (2013) Gang Zhao et al. ATHEROSCLEROSIS
- Comparison of Febuxostat and Allopurinol for Hyperuricemia in Cardiac Surgery Patients (NU-FLASH Trial)
- (2013) Akira Sezai et al. CIRCULATION JOURNAL
- Hyperuricemia and Hypertension
- (2012) Daniel I. Feig ADVANCES IN CHRONIC KIDNEY DISEASE
- Effect of Allopurinol on Blood Pressure: A Systematic Review and Meta-Analysis
- (2012) Vikram Agarwal et al. Journal of Clinical Hypertension
- Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
- (2010) M. Goicoechea et al. Clinical Journal of the American Society of Nephrology
- Hyperuricemia and incident hypertension: A systematic review and meta-analysis
- (2010) Peter C. Grayson et al. ARTHRITIS CARE & RESEARCH
- The association between serum urate levels and arterial stiffness/endothelial function in stroke survivors
- (2008) Faisel Khan et al. ATHEROSCLEROSIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started